NxStage Medical's shares hit a new 52-week low, despite the company's record sales and a forecast-beating 2nd quarter.

NxStage Medical (NSDQ:NXTM) notched a new low watermark for the year, despite reporting a strong 2nd quarter with records sales.
NXTM shares briefly hit $13.20 today, the lowest they've been in the last 52 weeks. Shares regained few cents by the early afternoon to trade at $13.34, still down 16% on the day.
InspireMD presents new 6 month follow-up data showing better survival rates for its MGuard stent
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
If you read nothing else today, make sure you're still in the know with MassDevice +3.